Pfizer Starts U.S. Trials of Experimental Covid-19 Vaccine

Pfizer Starts U.S. Trials of Experimental Covid-19 Vaccine (bloomberg.com)

The first U.S. patients have been dosed in a clinical trial testing whether four experimental messenger RNA (mRNA) vaccine candidates can prevent infection with the virus that causes 2019 coronavirus disease (COVID-19).

The trials are being conducted at the NYU Grossman School of Medicine and the University of Maryland School of Medicine, the drugmaker said Tuesday.

nyulangone.org

Submitted by mo2 on Wed, 05/06/2020 - 02:15